openPR Logo
Press release

ENT Disorder Treatment Market 2019 | See Incredible Growth by Top Players Sanofi, AstraZeneca, Novartis AG, Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Pharmaceuticals, Otonomy Inc

08-22-2019 07:46 AM CET | Health & Medicine

Press release from: Coherent Market Insights

ENT Disorder Treatment

ENT Disorder Treatment

The Global ENT Disorder Treatment Market, by Organ Type (Ear, Nose, and Throat), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 9,521.1 million in 2016 and is projected to exhibit a CAGR of 3.2% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights.

The ENT Disorders treatment market is expected to gain significant traction with increasing incidence of ENT disorders and increasing environmental pollution globally. According to an article published by Harvard Medical School and Teaching Hospital, 2017, over 360 million people across the globe are suffering from hearing loss and over half of this population can be treated with proper medication and care.

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1326

Manufacturers are focusing on development new and innovative treatments and therapies for ENT disorders for both adult and pediatric segments, in order to maintain their market share. For instance, Otonomy, Inc. — a U.S. based drug manufacturer — received FDA approval for OTIPRIO (ciproflaxin otic suspension) in December 2015, for treatment of pediatric patients suffering with bilateral otitis media with effusion. In May 2012, Meda Pharmaceuticals received FDA approval for dymista (azelastine hydrochloride and fluticasone propionate) for the treatment of seasonal allergic rhinitis that can be consumed by intranasal administration or sprayed suspension. Furthermore, in June 2017, Inspire Medical Systems received FDA approval for Inspire 3028 neurostimulator for the treatment of obstructive sleep apnea.

Key players are focusing on strategic merger and acquisition strategies for development and commercialization of novel ENT therapeutics and medical devices. For instance, December 2017, Entellus Medical, Inc. — a leader in ENT drugs segment — entered a definitive merger agreement with Stryker Corporation for development of effective ENT solutions through collaboration. Moreover, in in July 2017, Entellus Medical acquired Spirox, Inc. a privately held company that manufactures, develops and markets ENT medical devices.

Among treatment type segment, drug segment holds a dominant position in the global ENT disorder treatment market. This is owing to drug being the first line of treatment in most of the ENT disorders.
Among end users, hospital segment holds a dominant position in the global ENT disorder treatment market, as most of the surgical, non-surgical as well as consultation procedures are conducted at hospitals.

Some of the major players operating in the global ENT disorder treatment market include Sanofi, AstraZeneca plc, Novartis AG, Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Pharmaceuticals, Otonomy Inc., Merck & Co., Dr. Reddys Laboratories Ltd., Allergan plc, Cochlear Ltd., Sonova Holding AG, Siemens Healthcare, Starkey Laboratories Inc., William Demant Holding A/S, Widex A/S, GN ReSound A/S, Sonic Innovations Inc., Panasonic Corp., Beltone, Rexton Inc., Avada Hearing Care, Miracle-Ear Inc., MED-EL GmbH, Nuear Hearing Aids Inc., Audiosync Inc., Bernafon, American Hearing Systems Inc., Unitron Hearing Inc., and Zounds Inc.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1326

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ENT Disorder Treatment Market 2019 | See Incredible Growth by Top Players Sanofi, AstraZeneca, Novartis AG, Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Pharmaceuticals, Otonomy Inc here

News-ID: 1824742 • Views: 295

More Releases from Coherent Market Insights

Biological Pesticide Market Business Opportunities 2019 | Key Players Dow Chemic …
Biological pesticides are compounds that contain natural agents derived from plants, animals, minerals, or bacteria, for managing agricultural pests, disease causing pathogens, and weeds. Biological pesticides can be classified into three types depending on their application, such as microbial pesticides, plant-incorporated protectants (PIPs), and biochemical pesticides. Microbial pesticides contain microorganisms such as virus, fungi, and bacteria, whereas PPIs are substances produced through genetic material assimilated in a plant. Biochemicals are
Biolubricants Market Growth 2019: Top Vendors Exxon Mobil Corporation, Royal Dut …
Biolubricants are lubricants derived from vegetable oils or animal fat, and have properties such as biodegradability, non-toxicity, are non-bioaccumulative, and eco-friendly. Traditionally used lubricants were derived from petroleum-based oil, with poor degradability. Moreover, petroleum-based lubricants lead to environmental hazards by accumulating in water bodies and harm the aquatic life. Therefore, rising awareness regarding eco-friendly lubricant solutions is expected to drive demand of biolubricants in the near future. Get PDF Brochure of
Industrial Explosives Market Top Highlighted Vendors AEL Mining Services Ltd., …
The global industrial explosives market size is expected to witness potential gains in the future and register a significant CAGR of 6.6% over the forecast period (2019 - 2027). Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2966 Market Overview The explosives industry uses black powder, dynamite, and other chemicals to mine for minerals, break rock, clear fields, and construct roads. Explosives are used to deliver materials such as limestone, cement, and concrete that find application
Electric Linear Cylinders Market To Be Dominated by Keyplayers Bosch Rexroth AG, …
Global electric linear cylinders market was valued at US$ 595.7 Mn in 2018 and is expected to reach US$ 962.5 Mn in 2027, exhibiting a CAGR of 5.5% over the forecast period (2019–2027). Among verticals, food and beverages segment is expected to register the highest CAGR of 5.8% over the forecast period. Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3031 Technological advancements in design and development of electric linear cylinders and actuators is a

All 5 Releases


More Releases for ENT

United States ENT Endoscopes Market Report
In this report, the United States ENT Endoscopes market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share
ENT Chairs Market – Global Industry Insights, Trends
ENT is an area of medicine dealing with treatment of human body parts namely ear, nose, and throat (ENT) and few related areas such as neck and face. The medical disorders treated by ENT physicians include chronic ear infection, sinusitis, snoring, sleep apnea, hearing loss, allergies, hay fever, swallowing disorders, nosebleeds, hoarseness, dizziness and neck cancer. Ear, nose and throat specialists or otolaryngologists have specific tools for treating patients well
ENT Chairs Market – Global Industry Insights, 2025
ENT is an area of medicine dealing with treatment of human body parts namely ear, nose, and throat (ENT) and few related areas such as neck and face. The medical disorders treated by ENT physicians include chronic ear infection, sinusitis, snoring, sleep apnea, hearing loss, allergies, hay fever, swallowing disorders, nosebleeds, hoarseness, dizziness and neck cancer. Ear, nose and throat specialists or otolaryngologists have specific tools for treating patients well
2017 ENT Devices Market Embraces Advancements
In this report, the global ENT Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of ENT Devices in these regions, from 2012 to 2022 (forecast), covering North
ENT 2017_Conference_New Orleans, USA
On behalf of Allied Academies, it is our pleasure to invite you all to the “5th American Otolaryngology - ENT Surgery Conference” during November 09-10, 2017. New Orleans, Louisiana, USA. The International conference offers a focus on “Emerging Trends and Innovations in Otolaryngology-ENT”. For more details, visit us: http://ent.alliedacademies.com/ The ENT 2017 will cover the various key issues related to Head and Neck such as Head and Neck Surgery, Otolaryngology (ENT),
Jacksonville ENT Surgery welcomes new Medical Assistant
Jacksonville, Fla., Feb. 15, 2017 – Jacksonville ENT Surgery is pleased to welcome Lejla Juklo to their team as a certified medical assistant. Juklo will be responsible for taking a patient’s medical history, vital signs, preparing rooms for patient exams, assisting with allergy testing, CT scans and assisting the providers. She will be rotating between Jacksonville ENT Surgery’s five locations in Jacksonville, Jacksonville Beach and Lake City. Juklo is a